Showing results (71-80 of 93) with videos related to
Sort By:
Pageof 10
Vaccine|December 26, 2025
mRNA vaccines targeting Leptospira immunoglobulin-like proteins confer partial protection in a hamster model of leptospirosisTeerasit Techawiwattanaboon, Ratikarn Leekitcharoenphon, Mohamad-Gabriel Alameh, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2018
Brief Report: Safety and Tolerability of Inguinal Lymph Node Biopsy in Individuals With Acute HIV Infection in ThailandMichelle Chintanaphol, Carlo Sacdalan, Suthat Chottanapund, et al.The Journal of Allergy and Clinical Immunology|September 7, 2023
IFN-γ ELISpot-enabled machine learning for culprit drug identification in nonimmediate drug hypersensitivityYuda Chongpison, Sira Sriswasdi, Supranee Buranapraditkun, et al.Plos One|September 3, 2011
A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected ThaisSupranee Buranapraditkun, Ursula Hempel, Patrawadee Pitakpolrat, et al.Immunity|February 22, 2023
HIV rapidly targets a diverse pool of CD4+ T cells to establish productive and latent infectionsPierre Gantner, Supranee Buranapraditkun, Amélie Pagliuzza, et al.The Lancet Regional Health. Southeast Asia|September 2, 2025
Immunogenicity and safety of 'Comvigen', a bivalent SARS-CoV-2 vaccine, in comparison to Comirnaty bivalent vaccine in Thailand: a phase 2, non-inferiority randomised trialWatsamon Jantarabenjakul, Rapisa Nantanee, Thanyawee Puthanakit, et al.Frontiers in Plant Science|May 31, 2021
Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human PrimatesKonlavat Siriwattananon, Suwimon Manopwisedjaroen, Balamurugan Shanmugaraj, et al.Journal of Virus Eradication|June 16, 2025
Dynamic changes in immune cell subsets in blood and lymph node over the course of acute HIV infectionSupranee Buranapraditkun, Julie L Mitchell, Hiroshi Takata, et al.Nature Microbiology|November 14, 2022
Safety and immunogenicity of a prefusion non-stabilized spike protein mRNA COVID-19 vaccine: a phase I trialSivaporn Gatechompol, Wonngarm Kittanamongkolchai, Chutitorn Ketloy, et al.Journal of Virology|May 22, 2009
Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfectionJ Judy Chang, Sunee Sirivichayakul, Anchalee Avihingsanon, et al.Pageof 10